Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹73.1 Cr 13.8% 1.5% -37.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,277.5 Cr -4.1% 1.4% -7.6% Stock Analytics
KIRI INDUSTRIES ₹2,753.8 Cr -11.3% -14% -27.1% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,566.8 Cr 1.9% -6.1% -35% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,178.6 Cr 2.5% 10.4% 21% Stock Analytics
BODAL CHEMICALS ₹627.6 Cr -3.2% -2.8% -19.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

13.8%

1.5%

-37.5%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses